Gabather (GABA.ST) Stock Price

Gabather Price

OMX·CLOSED
0.02
​
Market closed

Revenue at Gabather has contracted by 75.0% per year over the past 4 years to 400.00 SEK. Gabather's net margin stands at -3,570,400.0%, down from -5,825.0% several years earlier.

Gabather stock price

Access this data via the Eulerpool API

Gabather business model & stock analysis

Gabather AB engages in the research and development of drug candidates for treatment of diseases affecting the central nervous system. The company is headquartered in Sodertalje, Stockholm. The company went IPO on 2014-11-03. The firm develops drug candidates for the treatment of several diseases originating in the central nervous system (CNS). The firm mainly focuses on anti-psychotics, anti-depressants and anxiolytics, analgesics, as well as conginition-enhancing treatments, including Alzheimer’s disease.

Frequently asked questions about Gabather

Converted at the current exchange rate, the Gabather share trades at 0.00 EUR (0.02 SEK).

The Gabather share (GABA.ST) is listed on 4 stock exchanges, including: Frankfurt (5J2.F), München (5J2.MU), Stockholm (GABA.ST).

The revenue cannot currently be calculated for Gabather.

The profit cannot currently be calculated for Gabather.

The P/E ratio cannot be calculated for Gabather at the moment.

The P/S cannot be calculated for Gabather currently.

The Eulerpool Quality Score for Gabather is 2/10.

The ISIN of Gabather is SE0010869552. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Gabather is A2JGN2. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Gabather is GABA.ST. The ticker symbol is used to trade Gabather shares on the stock exchange.

Fair ValueTerminal
0.02 SEK
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website gabather.com
Country
Sweden
Currency
SEK
Initial public offering
Nov 3, 2014
ISIN
SE0010869552
Cusip
W34064191
Market capitalization
11.80 M SEKMicro Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
—
P/B Ratio
24.28
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
185.70 %
Last updated Oct 10, 2026, 6:12 PM

Gabather Peer Group

Gabather Ticker

FRANKFURT · 5J2.FMUNICH · 5J2.MUSTOCKHOLM · GABA.STSTOCKHOLM · GABA.ST

Gabather FIGI

GABA:SF · BBG007F87583GABASEK:XS · BBG00KN72DB1GABASEK:XH · BBG00KN72DF7GABASEK:XF · BBG00KN72DH5GABASEK:XE · BBG00KN72DK1GABASEK:XJ · BBG00KN72DL0GABASEK:XL · BBG00KN72DM9GABASEK:XG · BBG00KN72DN8GABASEK:XO · BBG00KN72DP6GABASEK:XA · BBG00KN72DT2GABASEK:E1 · BBG00KN72DV9GABASEK:XT · BBG00KN72DW8

All fundamentals and in-depth analysis of Gabather

Our stock analysis for Gabather stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Gabather. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.